510(k) Report

510(k) · Cleared

Cleared

Quikscreen Multi (Mdma and Opi) Otc Drug Cup Test

K130275510(k) TraditionalCleared Sep 26, 2013234-day reviewClass II21 CFR 862.3650

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tianjin New Bay Bioresearch Co., Ltd. · DJG Enzyme Immunoassay, Opiates

Cleared on Sep 26, 2013 as substantially equivalent to K121166 (Guangzhou Wondfo Biotech Co., Ltd., 2012) after a 234-day review. Its family tree reaches back 1 generation to 2012.

Decided
Sep 26, 2013
Review
234 days
Class
Class II
Product code
DJG
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K121166 (2012). No later device cites it as a predicate yet.

  1. Root · 1 generation backK121166 Wondfo Multi-Drug Urine Test Cup Wondfo Multi-Drug Urine Test PanelGuangzhou Wondfo Biotech Co., Ltd. · 2012
  2. This deviceK130275 Quikscreen Multi (Mdma and Opi) Otc Drug Cup TestTianjin New Bay Bioresearch Co., Ltd. · 2013
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K121166Wondfo Multi-Drug Urine Test Cup Wondfo Multi-Drug Urine Test PanelGuangzhou Wondfo Biotech Co., Ltd.2012—
0 (this device)K130275Quikscreen Multi (Mdma and Opi) Otc Drug Cup TestTianjin New Bay Bioresearch Co., Ltd.2013—
FIG. 1 — Lineage of K130275, 2012–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DJG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DJG device

  1. #1 K232659 Dochek® Multi-Drug Urine Test Cup Rx, Dochek®…score 17.6 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K121166Wondfo Multi-Drug Urine Test Cup Wondfo Multi-Drug Urine Test Panel
Summary page 2
…creenT M Multi (MDMA and OPI) Drug Cup Test Device is substantially equivalent to predicate device (Guanzhou Wondfo Biotech Co Multi-Drug Urine Test Cup) cleared by FDA (K1 21 166) for its stated intended use. Product Desction: Quik creeng Muti (MDMA and OPI) Drug Cup Test Device is a convenient specimen co…
Guangzhou Wondfo Biotech Co., Ltd.2012—
†K071489Homecheck Multiple Drug Cup TestTianjin New Bay Bioresearch Co., Ltd.2008—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All DJG devices

DJG Enzyme Immunoassay, Opiates: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · DJG

3in 2025

2007: 22008: 22009: 22010: 62011: 62012: 52013: 52014: 92015: 122016: 22017: 42018: 52019: 32020: 52021: 32022: 22023: 102024: 52025: 32026 (partial year): 3
2007high 12 (2015) · low 2 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DJG

31in 2025

2010: 187 days median2011: 233 days median2012: 95 days median2013: 60 days median2014: 62 days median2015: 141 days median2017: 101 days median2018: 134 days median2019: 235 days median2020: 30 days median2021: 422 days median2023: 140 days median2024: 150 days median2025: 31 days median2026 (partial year): 157 days median
2007high 422 (2021) · low 30 (2020)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DJG

2in 2025

2011: 12019: 12025: 2
2007high 2 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DJG

1in 2025

2011: 42012: 12013: 42015: 32016: 22017: 12018: 12021: 22022: 12024: 32025: 1
2007high 4 (2011) · low 0 (2007)2025

MAUDE reports naming product code DJG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—00
20092—00
2010618700
2011623314
201259501
201356004
201496200
20151214103
20162—02
2017410101
2018513401
2019323510
202053000
2021342202
20222—01
20231014000
2024515003
202533121
202631570—

What is it indicated for?

The QuikScreen T M Multi (MDMA and OPI) Drug Cup Test consists of competitive binding, lateral flow immunochromatographic assays and provides a simple and rapid analytical screening procedure to simultaneously detect the drugs of abuse MDMA at or above the cutoff level of 500 nglml and OPI at or above the cutoff level of 300 nglml in human urine. The device is intended for prescription use and Over-The-Counter settings. Test Calibrator Cutof Opiate…

Read the full statement (148 words)

The QuikScreen T M Multi (MDMA and OPI) Drug Cup Test consists of competitive binding, lateral flow immunochromatographic assays and provides a simple and rapid analytical screening procedure to simultaneously detect the drugs of abuse MDMA at or above the cutoff level of 500 nglml and OPI at or above the cutoff level of 300 nglml in human urine. The device is intended for prescription use and Over-The-Counter settings.

Test Calibrator Cutof

Opiate Morphine 300 nglml

MOMA (+/-)-3,4Mcthylene- 500 ng/ml

dioxymethamphetamine

The assay provides only a preliminary analytical test result. A more specific alternative chemical method must be used to obtain a confirmed analytical result. GCIMS or LC/MS is the preferred confirmatory method. Clinical and professional judgment should be exercised with any drug of abuse test result, particularly when preliminary results are used. The assay does not distinguish whether OPI or MDMA is being taken therapeutically or abused.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K130275: Quikscreen Multi (Mdma and Opi) Otc Drug Cup Test.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K130275

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026